Transcription factor C/EBPα is a master regulator of myelopoiesis and its inactivation is associated with acute myeloid leukemia. Deregulation of C/EBPα by microRNAs during granulopoiesis or acute myeloid leukemia development has not been studied. Here we show that oncogenic miR-182 is a strong regulator of C/EBPα. Moreover, we identify a regulatory loop between C/EBPα and miR-182. While C/EBPα blocks miR-182 expression by direct promoter binding during myeloid differentiation, enforced expression of miR-182 reduces C/EBPα protein level and impairs granulopoiesis in vitro and in vivo. In addition, miR-182 expression is highly elevated particularly in acute myeloid leukemia patients with C-terminal CEBPA mutations, thereby depicting a mechanism by which C/EBPα blocks miR-182 expression. Furthermore, we present miR-182 expression as a prognostic marker in cytogenetically high-risk acute myeloid leukemia patients. Our data demonstrate the importance of a controlled balance between C/EBPα and miR-182 for the maintenance of healthy granulopoiesis.C/EBPα is a critical transcription factor involved in myelopoiesis and its inactivation is associated with acute myeloid leukemia (AML). Here the authors show a negative feedback loop between C/EBPα and miR-182 and identify this miRNA as a marker of high-risk AML.

Cancer Science Institute National University of Singapore 14 Medical Drive Singapore 117599 Singapore

Division of Hematology and Oncology Leipzig University Hospital Johannisallee 32a Leipzig 04103 Germany

Fraunhofer Institute for Cell Therapy and Immunology Perlickstraße 1 Leipzig 04103 Germany

Harvard Stem Cell Institute Harvard Medical School 3 Blackfan Circle Boston MA 02115 USA

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Videnska 1083 Prague 4 142 20 Czech Republic

See more in PubMed

Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381:484–495. doi: 10.1016/S0140-6736(12)61727-9. PubMed DOI

Vardiman JW, et al. The 2008 revision of the world health organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951. doi: 10.1182/blood-2009-03-209262. PubMed DOI

Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer. 2003;3:89–101. doi: 10.1038/nrc989. PubMed DOI

Castilla LH. C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals. Cancer Cell. 2008;13:289–291. doi: 10.1016/j.ccr.2008.03.009. PubMed DOI

Lin FT, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc. Natl Acad. Sci. USA. 1993;90:9606–9610. doi: 10.1073/pnas.90.20.9606. PubMed DOI PMC

Pabst T, Mueller BU. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin. Cancer Res. 2009;15:5303–5307. doi: 10.1158/1078-0432.CCR-08-2941. PubMed DOI

Pabst T, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat. Genet. 2001;27:263–270. doi: 10.1038/85820. PubMed DOI

Lin TC, et al. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia. Leukemia. 2011;25:32–40. doi: 10.1038/leu.2010.222. PubMed DOI

Radomska HS, et al. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J. Exp. Med. 2006;203:371–381. doi: 10.1084/jem.20052242. PubMed DOI PMC

Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat. Med. 2011;17:64–70. doi: 10.1038/nm.2266. PubMed DOI PMC

Hegde VL, et al. Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Delta9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein alpha by microRNA-690. J. Biol. Chem. 2013;288:36810–36826. doi: 10.1074/jbc.M113.503037. PubMed DOI PMC

Hackanson B, et al. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res. 2008;68:3142–3151. doi: 10.1158/0008-5472.CAN-08-0483. PubMed DOI

Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell. Biol. 2009;10:116–125. doi: 10.1038/nrm2621. PubMed DOI PMC

Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010;11:597–610. PubMed

Zhang X, et al. MicroRNA-101 suppresses tumor cell proliferation by Acting as an endogenous proteasome inhibitor via targeting the proteasome assembly factor POMP. Mol Cell. 2015;59:243–257. doi: 10.1016/j.molcel.2015.05.036. PubMed DOI

Ivey KN, Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem. Cell. 2010;7:36–41. doi: 10.1016/j.stem.2010.06.012. PubMed DOI

Guo S, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. USA. 2010;107:14229–14234. doi: 10.1073/pnas.0913574107. PubMed DOI PMC

Fontana L, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007;9:775–787. doi: 10.1038/ncb1613. PubMed DOI

Johnnidis JB, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451:1125–1129. doi: 10.1038/nature06607. PubMed DOI

Gerloff D, et al. NF-kappaB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia. 2015;29:535–547. doi: 10.1038/leu.2014.231. PubMed DOI PMC

Brauer-Hartmann D, et al. PML/RARalpha -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia. Cancer Res. 2015;75:3411–3424. doi: 10.1158/0008-5472.CAN-14-3521. PubMed DOI PMC

Katzerke C, et al. Transcription factor C/EBPalpha-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia. Blood. 2013;122:2433–2442. doi: 10.1182/blood-2012-12-472183. PubMed DOI PMC

Pulikkan JA, et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood. 2010;115:1768–1778. doi: 10.1182/blood-2009-08-240101. PubMed DOI PMC

Pulikkan JA, et al. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood. 2010;116:5638–5649. doi: 10.1182/blood-2010-04-281600. PubMed DOI PMC

Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood. 2003;102:1267–1275. doi: 10.1182/blood-2003-02-0477. PubMed DOI

Zhang H, et al. Sox4 is a key oncogenic target in C/EBPalpha mutant acute myeloid leukemia. Cancer Cell. 2013;24:575–588. doi: 10.1016/j.ccr.2013.09.018. PubMed DOI PMC

Alberich-Jorda M, et al. C/EBPgamma deregulation results in differentiation arrest in acute myeloid leukemia. J. Clin. Invest. 2012;122:4490–4504. doi: 10.1172/JCI65102. PubMed DOI PMC

Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br. J. Cancer. 2010;103:275–284. doi: 10.1038/sj.bjc.6605751. PubMed DOI PMC

Song L, et al. TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. J. Clin. Invest. 2012;122:3563–3578. doi: 10.1172/JCI62339. PubMed DOI PMC

Sachdeva M, et al. MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J. Clin. Invest. 2014;124:4305–4319. doi: 10.1172/JCI77116. PubMed DOI PMC

Ye M, et al. C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat. Cell. Biol. 2013;15:385–394. doi: 10.1038/ncb2698. PubMed DOI PMC

Niebuhr B, et al. Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML) Leukemia. 2009;23:978–983. doi: 10.1038/leu.2008.332. PubMed DOI

Lumayag S, et al. Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration. Proc. Natl Acad. Sci. USA. 2013;110:E507–E516. doi: 10.1073/pnas.1212655110. PubMed DOI PMC

D’Alo F, et al. The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood. 2003;102:3163–3171. doi: 10.1182/blood-2003-02-0479. PubMed DOI

Green CL, et al. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J. Clin. Oncol. 2010;28:2739–2747. doi: 10.1200/JCO.2009.26.2501. PubMed DOI

TCGA Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013;368:2059–2074. doi: 10.1056/NEJMoa1301689. PubMed DOI PMC

Zhang P, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 2004;21:853–863. doi: 10.1016/j.immuni.2004.11.006. PubMed DOI

Liu J, et al. PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1-ETO fusion gene. Leukemia. 2012;26:117–126. doi: 10.1038/leu.2011.178. PubMed DOI

Souza LM, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232:61–65. doi: 10.1126/science.2420009. PubMed DOI

Lieschke GJ, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84:1737–1746. PubMed

Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood. 1999;94:560–571. PubMed

Johansen LM, et al. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol. Cell Biol. 2001;21:3789–3806. doi: 10.1128/MCB.21.11.3789-3806.2001. PubMed DOI PMC

Cammenga J, et al. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34 + cells. Blood. 2003;101:2206–2214. doi: 10.1182/blood-2002-05-1546. PubMed DOI

Liss A, et al. The gene signature in CCAAT-enhancer-binding protein alpha dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors. Haematologica. 2014;99:697–705. doi: 10.3324/haematol.2013.093278. PubMed DOI PMC

Slomiany BA, D’Arigo KL, Kelly MM, Kurtz DT. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol. Cell Biol. 2000;20:5986–5997. doi: 10.1128/MCB.20.16.5986-5997.2000. PubMed DOI PMC

Kirstetter P, et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer. Cell. 2008;13:299–310. doi: 10.1016/j.ccr.2008.02.008. PubMed DOI

Porse BT, et al. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell. 2001;107:247–258. doi: 10.1016/S0092-8674(01)00516-5. PubMed DOI

Porse BT, et al. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J. Exp. Med. 2005;202:85–96. doi: 10.1084/jem.20050067. PubMed DOI PMC

Santana-Lemos BA, et al. The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated. Haematologica. 2011;96:617–620. doi: 10.3324/haematol.2010.028365. PubMed DOI PMC

Pabst T, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat. Med. 2001;7:444–451. doi: 10.1038/86515. PubMed DOI

Marcucci G, et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J. Clin. Oncol. 2013;31:2086–2093. doi: 10.1200/JCO.2012.45.6228. PubMed DOI PMC

Pedranzini L, et al. Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+ 38- compartment. Leuk. Res. 2010;34:1287–1295. doi: 10.1016/j.leukres.2010.02.012. PubMed DOI

Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer. 2009;9:785–797. doi: 10.1038/nrc2696. PubMed DOI PMC

O’Connell RM, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008;205:585–594. doi: 10.1084/jem.20072108. PubMed DOI PMC

Bousquet M, Harris MH, Zhou B, Lodish HF. MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. USA. 2010;107:21558–21563. doi: 10.1073/pnas.1016611107. PubMed DOI PMC

Velu CS, et al. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J. Clin. Invest. 2014;124:222–236. doi: 10.1172/JCI66005. PubMed DOI PMC

Favreau AJ, Sathyanarayana P. miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia. Leuk. Res. 2012;36:334–341. doi: 10.1016/j.leukres.2011.09.027. PubMed DOI PMC

Stittrich AB, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 2010;11:1057–1062. doi: 10.1038/ni.1945. PubMed DOI

De Obaldia ME, et al. T cell development requires constraint of the myeloid regulator C/EBP-alpha by the Notch target and transcriptional repressor Hes1. Nat. Immunol. 2013;14:1277–1284. doi: 10.1038/ni.2760. PubMed DOI PMC

Ma O, Hong S, Guo H, Ghiaur G, Friedman AD. Granulopoiesis requires increased C/EBPalpha compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells. PLoS ONE. 2014;9:e95784. doi: 10.1371/journal.pone.0095784. PubMed DOI PMC

Shlush LI, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–333. doi: 10.1038/nature13038. PubMed DOI PMC

Braun J, Misiak D, Busch B, Krohn K, Huttelmaier S. Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification) Nucleic Acids Res. 2014;42:e66. doi: 10.1093/nar/gku127. PubMed DOI PMC

Mullokandov G, et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods. 2012;9:840–846. doi: 10.1038/nmeth.2078. PubMed DOI PMC

Salomonis N, et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl Acad. Sci. USA. 2010;107:10514–10519. doi: 10.1073/pnas.0912260107. PubMed DOI PMC

MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia